In the fight against cancer, early detection is key – and the CTC AutoProcessor is leading the charge. Engineered with precision and powered by innovation, this cutting-edge technology is poised to transform the way we detect and monitor cancer through circulating tumor cell (CTC) analysis.
Benefits of CTC AutoProcessor
Only a small amount of blood
High accuracy
Monitoring cancer risk
Evaluating treatment efficacy
Results received in 5 days
Who to Use CTC AutoProcessor
With abnormal tumor marker levels
With abnormal imaging results
With abnormal fecal occult blood tests or smear tests
With family history of cancer
Who have had cancer before
Who care about their own health
Through a simple blood test and precise automated experimental procedures, the exclusive CTC negative selection could help you to monitor various types of cancer.
Ready to elevate your hospital or health center’s processes and enhance patient care? Contact us now to discover how our innovative solutions can revolutionize your healthcare practices and improve overall health outcomes.